DTRT Health Acquisition Corp. (DTRTW) Stock Analysis
DELISTED 2023
What happened to DTRT Health Acquisition Corp. (DTRTW) stock?
DTRT Health Acquisition Corp. (DTRTW) no longer trades on public markets. It was delisted in February 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DTRT Health Acquisition Corp. (DTRTW) trades at $0.0005. DTRT Health Acquisition Corp. is a shell company focused on merging with or acquiring an operating business, primarily within the healthcare sector. Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for DTRTW: DTRTW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DTRTW against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
DTRT Health Acquisition Corp. (DTRTW) Financial Services Profile
DTRT Health Acquisition Corp., a special purpose acquisition company (SPAC) formed in 2021, seeks a merger, asset acquisition, or similar business combination, primarily targeting the healthcare industry. Based in Oak Brook, Illinois, it currently has no operational activities and a P/E ratio of 29.10.
What Is the Investment Thesis for DTRTW?
DTRT Health Acquisition Corp. presents a speculative investment opportunity tied to its ability to identify and merge with a high-growth healthcare company. The company's current valuation, reflected in its P/E ratio of 29.10, is based on the potential of a future acquisition. Key value drivers include the management team's expertise in deal-making and the attractiveness of the healthcare sector for investment. Growth catalysts depend on the successful identification and completion of a merger within the next 12-24 months. Failure to do so could lead to liquidation. Potential risks include increased competition for attractive acquisition targets, unfavorable market conditions impacting deal valuations, and regulatory hurdles in the healthcare industry. Investors should carefully consider these factors before investing.
Based on FMP financials and quantitative analysis
DTRTW Key Highlights
DTRT Health Acquisition Corp. was incorporated in 2021, indicating its relatively recent formation as a SPAC.
- The company's primary objective is to pursue a merger, capital stock exchange, or similar business combination with an operating business, primarily in the healthcare sector.
- DTRT Health Acquisition Corp. is based in Oak Brook, Illinois, providing a central location for its operations.
- The company currently has no significant operations, highlighting its status as a blank check company.
- The P/E ratio is 29.10, reflecting market expectations of a successful acquisition.
Who Are DTRTW's Competitors?
DTRTW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
| APXTW Apex Treasury Corporation | $0.35 | -5.41% | $1.89B | 66 |
| APXT Apex Technology Acquisition Corp. | $10.12 | -0.05% | $1.89B | 64 |
| APXTU Apex Treasury Corporation | $10.26 | +0.39% | $1.89B | 64 |
| WCHS Winchester Holding Group | $5.01 | +0.00% | $532M | 63 |
| MESH Meshflow Acquisition Corp. | $10.04 | -0.05% | $433M | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DTRTW's Key Strengths?
Dedicated to finding merger target.
- Access to capital through IPO.
- Flexibility to pursue various transaction structures.
- Potential for high returns if a successful merger is completed.
What Are DTRTW's Weaknesses?
No existing operations or revenue streams.
- Dependence on identifying and completing a merger within a limited timeframe.
- Competition from other SPACs seeking attractive acquisition targets.
- Potential for conflicts of interest between management and shareholders.
What Could Drive DTRTW Stock Higher?
Announcement of a potential merger target within the next 6-12 months.
- Progress in negotiations with potential merger targets.
- Positive developments in the healthcare sector driving investor interest.
What Are the Key Risks for DTRTW?
Failure to identify and complete a merger within the specified timeframe, leading to liquidation.
- Increased competition from other SPACs seeking attractive acquisition targets.
- Unfavorable market conditions impacting deal valuations.
- Regulatory hurdles in the healthcare industry.
- Dependence on the management team's expertise and deal-making abilities.
What Are the Growth Opportunities for DTRTW?
- Successful Merger Completion: DTRT Health Acquisition Corp.'s primary growth opportunity lies in successfully completing a merger with a high-growth healthcare company. The market for healthcare acquisitions is substantial, with deal values reaching billions of dollars annually. A successful merger would provide DTRT Health Acquisition Corp. with immediate operational capabilities and revenue streams, driving significant shareholder value. The timeline for this is within the next 12-24 months.
- Strategic Sector Focus: By focusing on the healthcare sector, DTRT Health Acquisition Corp. can capitalize on the industry's robust growth and innovation. This strategic focus allows DTRT Health Acquisition Corp. to target companies with high growth potential and strong competitive advantages.
- Leveraging Market Expertise: DTRT Health Acquisition Corp. can leverage the expertise of its management team to identify and evaluate potential acquisition targets. A strong management team with a proven track record in deal-making can significantly increase the likelihood of a successful merger. This expertise provides DTRT Health Acquisition Corp. with a competitive advantage in the crowded SPAC market.
- Capitalizing on Favorable Market Conditions: DTRT Health Acquisition Corp. can capitalize on favorable market conditions, such as low interest rates and strong investor demand for healthcare investments. These conditions can make it easier to raise capital and complete a merger on attractive terms. However, it is important to note that market conditions can change rapidly, so DTRT Health Acquisition Corp. must be prepared to adapt to changing circumstances.
- Expanding into Related Sectors: While initially focused on the healthcare sector, DTRT Health Acquisition Corp. could potentially expand its scope to include related sectors, such as biotechnology or pharmaceuticals. This would broaden the pool of potential acquisition targets and increase the company's growth opportunities. However, it would also require the company to develop expertise in these new sectors.
What Are DTRTW's Competitive Advantages?
- Access to capital raised through the IPO.
- Management team's expertise in deal-making and the healthcare sector.
- Established network of contacts within the healthcare industry.
- First-mover advantage in identifying attractive acquisition targets.
What Does DTRTW Do?
DTRT Health Acquisition Corp. was founded in 2021 with the explicit purpose of identifying and merging with a promising operating business. As a special purpose acquisition company, or SPAC, DTRT Health Acquisition Corp. does not engage in any direct operational activities of its own. Instead, its sole focus is on locating a suitable target company, primarily within the healthcare sector, with which to complete a business combination. This can take the form of a traditional merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or another similar transaction. The company's structure allows a private company to become publicly listed more rapidly than through a traditional initial public offering (IPO). Once a target is identified, DTRT Health Acquisition Corp. will seek to leverage its existing capital and market access to facilitate the merger. The success of DTRT Health Acquisition Corp. hinges entirely on its ability to identify and successfully merge with a target company that offers substantial growth potential and shareholder value. Headquartered in Oak Brook, Illinois, DTRT Health Acquisition Corp. represents a blank check company seeking to create value through strategic acquisitions in the healthcare space.
What Products and Services Does DTRTW Offer?
- Identify potential merger targets, primarily in the healthcare industry.
- Evaluate the financial and operational performance of target companies.
- Negotiate merger agreements and other transaction documents.
- Raise capital to finance the merger.
- Complete the merger and integrate the target company into the DTRT Health Acquisition Corp. structure.
- Seek to enhance shareholder value through strategic acquisitions.
How Does DTRTW Make Money?
- DTRT Health Acquisition Corp. operates as a special purpose acquisition company (SPAC).
- The company raises capital through an initial public offering (IPO).
- The capital is held in a trust account and used to finance a merger with a target company.
- If a merger is not completed within a specified timeframe, the capital is returned to investors.
What Industry Does DTRTW Operate In?
DTRT Health Acquisition Corp. operates within the special purpose acquisition company (SPAC) segment of the financial services industry. SPACs have gained prominence as alternative pathways for private companies to go public, particularly in sectors like healthcare. The industry is characterized by intense competition among SPACs seeking attractive acquisition targets. Market trends include increased regulatory scrutiny and investor demand for transparency. DTRT Health Acquisition Corp. aims to capitalize on the growing demand for healthcare innovation by merging with a promising company in the sector.
Who Are DTRTW's Key Customers?
- DTRT Health Acquisition Corp.'s 'customers' are its shareholders, who invest in the company with the expectation of a successful merger.
- Potential target companies in the healthcare sector seeking to go public through a merger with a SPAC.
- Institutional investors who may provide funding for the merger.
Company Profile
DTRT Health Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Oak Brook, US. DTRTW has traded publicly since 2021.
DTRTW Financials
Bull Case vs Bear Case
Bull Case
- Dedicated to finding merger target.
- Access to capital through IPO.
- Flexibility to pursue various transaction structures.
- Potential for high returns if a successful merger is completed.
Bear Case
- No existing operations or revenue streams.
- Dependence on identifying and completing a merger within a limited timeframe.
- Competition from other SPACs seeking attractive acquisition targets.
- Potential for conflicts of interest between management and shareholders.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
DTRTW Latest News
No recent news available for DTRTW.
Classification
Industry Shell CompaniesDTRT Health Acquisition Corp. Financial Services Stock: Key Questions Answered
What happened to DTRT Health Acquisition Corp. (DTRTW) stock?
DTRT Health Acquisition Corp. (DTRTW) no longer trades on public markets. It was delisted in February 2023. The figures below are historical and are not a current quote.
Can I still buy DTRTW shares?
No. DTRTW stopped trading on public markets in February 2023, so the shares are not available through a broker. Anything you see quoted for DTRTW elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before DTRTW stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to DTRT Health Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does DTRT Health Acquisition Corp. do?
DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC) focused on merging with or acquiring a company in the healthcare sector. As a blank check company, it raises capital through an initial public offering (IPO) with the intent of using those funds to acquire an existing operating business.
What do analysts say about DTRTW stock?
As of 2026-03-18, there is no available analyst coverage for DTRT Health Acquisition Corp. due to its nature as a SPAC without current operations. The stock's performance is entirely dependent on the market's perception of its ability to find and merge with a valuable healthcare company.
What are the main risks for DTRTW?
The primary risk for DTRT Health Acquisition Corp. is the failure to identify and complete a merger within the allotted timeframe, which would result in the liquidation of the company and a return of capital to investors.
How does DTRT Health Acquisition Corp. make money in financial services?
As a SPAC, DTRT Health Acquisition Corp. does not generate revenue in the traditional sense. Its business model revolves around identifying and merging with a target company. The SPAC's sponsors typically receive equity in the merged entity as compensation for their efforts in sourcing and executing the deal.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- The analysis is limited by the lack of operational data for DTRT Health Acquisition Corp.